New affordable hepatitis C combination treatment shows 97 percent cure rate
(Drugs for Neglected Diseases Initiative) The sofosbuvir/ravidasvir combination treatment for hepatitis C has been shown to be safe and effective, with extremely high cure rates, according to interim results from the Phase II/III STORM-C-1 trial presented by DNDi at the International Liver Conference in Paris.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Conferences | Hepatitis | Hepatitis C | International Medicine & Public Health | Liver | Urology & Nephrology